Nurix Therapeutics, Inc. (NRIX) Insider Trading -- Recent Executive & Director Transactions
4 insiders reported 127 Form 4 transactions for Nurix Therapeutics, Inc. (NRIX) over the past 18 months (most recent 2026-10-02). Recent activity: Ring Christine (Chief Legal Officer) Buy 5,786 shares, Ring Christine (Chief Legal Officer) Sell 5,786 shares, Ring Christine (Chief Legal Officer) Buy 5,787 shares, Ring Christine (Chief Legal Officer) Sell 5,387 shares, Ring Christine (Chief Legal Officer) Sell 400 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Ring Christine | Chief Legal Officer | Buy | 5,786 | $50,454 |
| 2026-10-02 | Ring Christine | Chief Legal Officer | Sell | 5,786 | $134,149 |
| 2026-09-02 | Ring Christine | Chief Legal Officer | Buy | 5,787 | $50,463 |
| 2026-09-02 | Ring Christine | Chief Legal Officer | Sell | 5,387 | $138,417 |
| 2026-09-02 | Ring Christine | Chief Legal Officer | Sell | 400 | $10,655 |
| 2026-09-01 | Hansen Gwenn | Chief Scientific Officer | Buy | 1,452 | $2,701 |
| 2026-09-01 | Hansen Gwenn | Chief Scientific Officer | Sell | 1,452 | $36,982 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | Buy | 4,356 | $8,102 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | Sell | 1,500 | $35,803 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | Sell | 2,611 | $64,339 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | Sell | 4,356 | $108,900 |
| 2026-08-04 | van Houte Hans | Chief Financial Officer | Sell | 2,967 | $73,129 |
| 2026-08-04 | van Houte Hans | Chief Financial Officer | Sell | 1,794 | $42,861 |
| 2026-08-03 | Ring Christine | Chief Legal Officer | Buy | 5,787 | $50,463 |
| 2026-08-03 | Ring Christine | Chief Legal Officer | Sell | 16,589 | $382,358 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | Buy | 3,750 | $0 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | Buy | 3,750 | $0 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | Buy | 3,750 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | Buy | 2,858 | $0 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | Buy | 2,858 | $0 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | Buy | 2,858 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | Buy | 3,572 | $0 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | Buy | 3,572 | $0 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | Buy | 3,572 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | Sell | 3,847 | $89,954 |
Source: SEC Form 4 filings · as of 2026-10-02